These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Experimental studies of the pathogenesis of pulmonary vascular obstructive disease. Hawe A; Tsakiris AG; Rastelli GC; Titus JL; McGoon DC J Thorac Cardiovasc Surg; 1972 Apr; 63(4):652-64. PubMed ID: 5014649 [No Abstract] [Full Text] [Related]
6. Regulation of the pulmonary circulation. Linde LM; Simmons DH UCLA Forum Med Sci; 1970; 10():321-9. PubMed ID: 5521145 [No Abstract] [Full Text] [Related]
7. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Viswanathan S; Kumar RK Catheter Cardiovasc Interv; 2008 Apr; 71(5):665-70. PubMed ID: 18360864 [TBL] [Abstract][Full Text] [Related]
8. [A correlative study of the pulmonary flow-gram and left atrium pressure]. Zhang XY Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Aug; 15(4):230-2. PubMed ID: 3440426 [No Abstract] [Full Text] [Related]
9. The mechanism of pulmonary hypertension in pulmonary embolism. Widimsky J Bull Physiopathol Respir (Nancy); 1970; 6(1):147-84. PubMed ID: 5521981 [No Abstract] [Full Text] [Related]
10. [Changes in the pulmonary vascular bed after lung resection (functional and morphological study at the macro- and microscopic level)]. Berezovskiĭ OI Arkh Patol; 1968; 30(8):43-8. PubMed ID: 5725446 [No Abstract] [Full Text] [Related]
11. [Pulmonary flow velocity patterns in patients with pulmonary hypertension: a study using pulsed Doppler echocardiography combined with two-dimensional echocardiography (author's transl)]. Matsuda M; Sugishita Y; Yamaguchi T; Tamura T; Ito I J Cardiogr; 1981 Jun; 11(2):603-14. PubMed ID: 7320540 [No Abstract] [Full Text] [Related]
12. [Certain aspects of pulmonary hypertension]. Passowicz-Muszyńska E Wiad Lek; 1989 Nov 15-Dec 15; 42(22-24):1122-7. PubMed ID: 2700260 [TBL] [Abstract][Full Text] [Related]
13. ETIOLOGY OF PULMONARY VASCULAR DISEASE. EVIDENCE FOR OXYGEN AS AN ETIOLOGIC AGENT. II. LIDDLE HV; FYLER DC Guthrie Clin Bull; 1964 Apr; 33():151-60. PubMed ID: 14140944 [No Abstract] [Full Text] [Related]
14. Experimental extreme pulmonary hypertension and vascular disease in relation to polycythemia. Saldaña ME; Harley RA; Liebow AA; Carrington CB Am J Pathol; 1968 May; 52(5):935-81. PubMed ID: 5646512 [No Abstract] [Full Text] [Related]
15. Current perspectives modern hemodynamic evaluation of the pulmonary circulation. Application to pulmonary arterial hypertension and embolic pulmonary hypertension. Naeije R; Vizza D Ital Heart J; 2005 Oct; 6(10):784-8. PubMed ID: 16270467 [TBL] [Abstract][Full Text] [Related]
16. Aortopulmonary collaterals in single-ventricle congenital heart disease: how much do they count? Powell AJ Circ Cardiovasc Imaging; 2009 May; 2(3):171-3. PubMed ID: 19808589 [No Abstract] [Full Text] [Related]
17. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Limsuwan A; Khosithseth A; Wanichkul S; Khowsathit P Catheter Cardiovasc Interv; 2009 Jan; 73(1):98-104. PubMed ID: 19089967 [TBL] [Abstract][Full Text] [Related]
18. The Q-I interval in mitral stenosis with pulmonary hypertension. Macieira-Coelho E; Faleiro LL Bibl Cardiol; 1969; 26():311-6. PubMed ID: 5402359 [No Abstract] [Full Text] [Related]